Neurobiological and clinical characteristics of amnestic patients with Lewy body pathology
Jesús Silva‐Rodríguez, Alexis Moscoso, Miguel Labrador‐Espinosa, Pascual Sanchez‐Juan, Michael Schöll, Michel J. Grothe · 2025
Read Neurobiological and clinical characteristics of amnestic patients with Lewy body pathology by Jesús Silva‐Rodríguez, Alexis Moscoso, Miguel Labrador‐Espinosa, Pascual Sanchez‐Juan, Michael Schöll, Michel J. Grothe (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715473.txt.
Description
Memory loss points doctors toward Alzheimer's, but Lewy body disease can wear the same mask, and the two pathologies often share a brain. Jesús Silva-Rodríguez and co-authors separate the mixtures in a 2025 study of 872 patients from a major Alzheimer's cohort. Spinal fluid tests measured amyloid, tau, and a new seed assay for the Lewy protein.
Patients were sorted into four groups by their biomarker pattern, from neither pathology to both together. The team then compared demographics, gene risk, and brain metabolism across the groups. Between a third and three fifths of Alzheimer's patients carry Lewy pathology too, which reportedly steepens decline. Sorting amnestic patients by biology, the authors argue, should sharpen both diagnosis and trial design.
Catalog record
| CREATOR | Jesús Silva‐Rodríguez, Alexis Moscoso, Miguel Labrador‐Espinosa, Pascual Sanchez‐Juan, Michael Schöll, Michel J. Grothe |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |